Ribosome formation in rat liver: evidence for post-transcriptional control.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology; D001375:Azaguanine / Q000494:pharmacology; D002247:Carbon Isotopes; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism; D002499:Centrifugation, Density Gradient; D003513:Cycloheximide / Q000494:pharmacology; D003593:Cytoplasm / Q000378:metabolism; D003864:Depression, Chemical; D005246:Feedback; D007930:Leucine / Q000378:metabolism; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D008113:Liver Neoplasms / Q000378:metabolism*; D008297:Male; D008660:Metabolism / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000378:metabolism; D009963:Orotic Acid / Q000378:metabolism; D011691:Puromycin / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis*; D051381:Rats; D012270:Ribosomes / Q000254:growth & development / Q000378:metabolism*; D013268:Stimulation, Chemical; D013997:Time Factors; D014364:Tryptophan / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D002247:Carbon Isotopes; D011759:Pyrrolidines; D011691:Puromycin; D009963:Orotic Acid; D012313:RNA; D014364:Tryptophan; D003513:Cycloheximide; D007930:Leucine; D001375:Azaguanine